News

.

Dermatology Times will be reporting from the AAD annual meeting this week in San Diego. Visit our conference news page to follow the developments from the meeting.

.

Fear associated with perceived pain from injectable biologics has been shown to be successfully addressed by employing anchoring bias interventions, researchers report in JAMA Dermatology.

The microbiome is one of the most popular areas of skin research at present. Many dermatologic diseases are accompanied by abnormal microbiomes beginning with atopic dermatitis, says Dr. Zoe Diana Draelos in her monthly column, Cosmetic Conundrums.

Dermatologists recommend moisturizers for patients who suffer from atopic dermatitis, contact dermatitis and psoriasis. Some over-the-counter moisturizers contain allergens patients should avoid. For details, print our table-of-the-month.

In this issue of Dermatology Times, we feature pediatric dermatology research, beginning with advances in junctional epidermolysis bullosa that led to the development of new skin for one young patient.

Balancing a career or business, a family and a household is a given for many of us. When it comes to keeping cool and maintaining relationships with family, colleagues and our patients, communication and education are key. Here's how one tool can help.

Looking for how to build strong business relationships? Here's a checklist to help you connect more effectively with current and potential partners.

Pediatricians respond to the first successful gene therapy treatment for epidermolysis bullosa.

A daily capsule of a cocktail of probiotics may reduce both the severity symptoms in moderate atopic dermatitis and the need for topical corticosteroids to treat symptom flare ups in children.

Avoiding and treating vascular compromise with hyaluronic acid (HA) injections requires understanding the subtleties of underlying facial anatomy and keeping a well-stocked arsenal of treatments for impending necrosis.

PeDRA and NSP authors new consensus statement for pediatric psoriasis. Interdisciplinary care (dermatologist and pediatricians) is critical. Regular screening for common comorbidities is recommended.

Specific training criteria and phone management policy and procedures to help your dermatology practice blow the competition away.

Litigation is largely due to a practitioner’s lack of training and the lack of informed consent for the patient.

All children, but healthy controls, had a higher likelihood of behavioral issues. ADHD symptoms of attention, hyperactivity and impulse control, were higher in AD children. Quality of life lower in affected children.

A survey of pediatric dermatologists and rheumatologists reveals wide variation in how patients with pediatric morphea are treated.

The American Academy of Dermatology annual meeting - Feb. 16-20 in San Diego - will highlight the status of new systemic treatments for chronic skin conditions, such as moderate-to-severe atopic dermatitis and psoriasis; in addition to new treatments for inflammatory skin conditions. Bookmark this site to follow the developments.

Dermatologists should take ownership of screening patients for mental health concerns associated with their skin condition.

In this article, Drs. Lawrence Eichenfield and Jessica Sprague review some of the most significant findings and developments in pediatric dermatology from the last year beginning with the availability of biologic agents for pediatric psoriasis and atopic dermatitis.

Morgana Colombo, M.D., is partnering with Integrated Dermatology to lead its practice in Reston, Va., according to a news release.

Adam Friedman, M.D., was honored with the Innovations in Residency Training Award by the Journal of Drugs in Dermatology (JDD) at the Orlando Dermatology Aesthetic & Clinical Conference (ODAC) held in January.

The Food and Drug Administration accepted a new drug application for IDP-118 lotion (halobetasol propionate and tazarotene, Ortho Dermatologics), for the topical treatment of plaque psoriasis.

National Psoriasis Foundation has launched a new website specifically designed for the information needs of children and teens who have psoriatic arthritis.

The first patient has been dosed in the phase two study of PR022 (hypochlorous acid, Realm Therapeutics), a topical gel treatment for patients with atopic dermatitis.

Participants at the Aesthetic Academy named Kevin Sadati, D.O., a facial plastic surgeon based in Newport Beach, Calif., Best Aesthetic Doctor at its recent program.

Hologic’s Cynosure division announced the launch of an advanced radiofrequency device that has been cleared by the U.S. Food and Drug Administration to facial fine lines and wrinkles, tighten skin through soft tissue coagulation, and improve the appearance of cellulite.

atmosphere-Healthcare is a new turnkey company that offers a visual platform for medical office environments aimed at reducing stress, anxiety and increasing patient satisfaction.

Cartessa Aesthetics has signed an exclusive deal with Italian corporation DEKA M.E.L.A. to introduce a laser hair removal device to the United States.

Ortho Dermatologics has announced that RETIN-A MICRO® (tretinoin) gel microsphere 0.06% is now available commercially to healthcare professionals.